Search results
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock | The Motley Fool
The Motley Fool· 12 hours agoAs two of the world's largest and most prolific drugmakers, Pfizer (PFE -1.70%) and AstraZeneca (AZN...
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
Zacks via Yahoo Finance· 12 hours agoAstraZeneca's (AZN) shares decline as it fails to achieve statistically significant overall survival...
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock? | The Motley Fool
The Motley Fool· 14 hours agoAstraZeneca (AZN -0.70%) is embarking on a fresh business plan that will see it grow significantly...
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Benzinga via Yahoo Finance· 8 hours agoTuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first...
Chasing Merck, AstraZeneca's PCSK9 inhibitor lowers cholesterol in phase 1 test
FierceBiotech· 11 hours agoAstraZeneca’s small molecule lowered levels of “bad” cholesterol by more than half in patients who...
Why Is AstraZeneca Stock Trading Lower On Tuesday?
Benzinga via Yahoo Finance· 1 day agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) said the survival results did not reach statistical significance in the overall trial population in the...
Here's Why We Think AstraZeneca (LON:AZN) Is Well Worth Watching
Simply Wall St. via Yahoo Finance· 6 days agoIf this kind of company isn't your style, you like companies that generate revenue, and even earn...
AstraZeneca’s (AZN) “Buy” Rating Reaffirmed at Citigroup
ETF DAILY NEWS· 24 hours agoCitigroup reissued their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a report published on Tuesday, Marketbeat reports. Several other analysts have also ...
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters via Yahoo News· 1 day agoAmgen's drug will be marketed under the name Bkemv. Biosimilars are close copies of complex...
Feds plan for smoother access to RSV infant shot
Politico· 10 hours agoThe government has repeatedly met with vaccine makers AstraZeneca and Sanofi in recent months to ensure there is enough supply early in the season after unanticipated demand ...